Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrataGraft SOMA for Full-Thickness Thermal Burns
NCT04765202Phase 2Terminated
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2021
- Primary completion
- Jun 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen in Thermal Burn, sponsored by Mallinckrodt Pharmaceuticals. Started Oct 2021; status: terminated.
02
Drugs
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT04765202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765202.